Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

TORCNTORCN
Showing 6 of 15 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in ADICET BIO INC

As of its Q3 2025 13F, Goldman Sachs held 3,751,617 shares of TORCN (Adicet Bio), worth $3M. Goldman Sachs' 13F filings listed TORCN from Q2 2022 to Q3 2025, 14 quarterly filings.

Final Value

$0

Final Shares

0

Total Value Change

-$5.4M

Total Shares Change

-3.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Exited
0
-100.0%
$00.0%—
0
2025-Q3
Decreased
3.8M
-0.0%
$3M0.0%—
0
2025-Q2
Decreased
3.8M
-1.7%
$2.3M0.0%—
0
2025-Q1
Increased
3.8M
+1.7%
$2.9M0.0%—
27
2024-Q4
Decreased
3.8M
-0.2%
$3.6M0.0%—
0
2024-Q3
Decreased
3.8M
-12.2%
$5.4M0.0%—
0

Other major holders of TORCN: RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used